ArticleNature communications2025

Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity.

Ana García García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.